Literature DB >> 26331372

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Michael C Haffner1, Christopher Weier1, Meng Meng Xu2, Ajay Vaghasia1, Bora Gürel3, Berrak Gümüşkaya3, David M Esopi1, Helen Fedor3, Hsueh-Li Tan3, Ibrahim Kulac3, Jessica Hicks3, William B Isaacs1,4, Tamara L Lotan1,3, William G Nelson1,3,4, Srinivasan Yegnasubramanian1, Angelo M De Marzo1,3,4.   

Abstract

Prostate cancer often manifests as morphologically distinct tumour foci and is frequently found adjacent to presumed precursor lesions such as high-grade prostatic intraepithelial neoplasia (HGPIN). While there is some evidence to suggest that these lesions can be related and exist on a pathological and morphological continuum, the precise clonal and temporal relationships between precursor lesions and invasive cancers within individual tumours remain undefined. Here, we used molecular genetic, cytogenetic, and histological analyses to delineate clonal, temporal, and spatial relationships between HGPIN and cancer lesions with distinct morphological and molecular features. First, while confirming the previous finding that a substantial fraction of HGPIN lesions associated with ERG-positive cancers share rearrangements and overexpression of ERG, we found that a significant subset of such HGPIN glands exhibit only partial positivity for ERG. This suggests that such ERG-positive HGPIN cells either rapidly invade to form adenocarcinoma or represent cancer cells that have partially invaded the ductal and acinar space in a retrograde manner. To clarify these possibilities, we used ERG expression status and TMPRSS2-ERG genomic breakpoints as markers of clonality, and PTEN deletion status to track temporal evolution of clonally related lesions. We confirmed that morphologically distinct HGPIN and nearby invasive cancer lesions are clonally related. Further, we found that a significant fraction of ERG-positive, PTEN-negative HGPIN and intraductal carcinoma (IDC-P) lesions are most likely clonally derived from adjacent PTEN-negative adenocarcinomas, indicating that such PTEN-negative HGPIN and IDC-P lesions arise from, rather than give rise to, the nearby invasive adenocarcinoma. These data suggest that invasive adenocarcinoma can morphologically mimic HGPIN through retrograde colonization of benign glands with cancer cells. Similar clonal relationships were also seen for intraductal carcinoma adjacent to invasive adenocarcinoma. These findings represent a potentially undervalued indicator of pre-existing invasive prostate cancer and have significant implications for prostate cancer diagnosis and risk stratification.
Copyright © 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  ERG; PTEN; clonality; ductal spreading; prostate cancer; prostatic intraepithelial neoplasia

Mesh:

Substances:

Year:  2015        PMID: 26331372      PMCID: PMC4715537          DOI: 10.1002/path.4628

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  59 in total

1.  Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.

Authors:  David Brocks; Yassen Assenov; Sarah Minner; Olga Bogatyrova; Ronald Simon; Christina Koop; Christopher Oakes; Manuela Zucknick; Daniel Bernhard Lipka; Joachim Weischenfeldt; Lars Feuerbach; Richard Cowper-Sal Lari; Mathieu Lupien; Benedikt Brors; Jan Korbel; Thorsten Schlomm; Amos Tanay; Guido Sauter; Clarissa Gerhäuser; Christoph Plass
Journal:  Cell Rep       Date:  2014-07-24       Impact factor: 9.423

2.  ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma.

Authors:  Thomas M Schneider; Adeboye O Osunkoya
Journal:  Mod Pathol       Date:  2014-01-10       Impact factor: 7.842

3.  Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer.

Authors:  Antje Krohn; Fabian Freudenthaler; Silvia Harasimowicz; Martina Kluth; Sarah Fuchs; Lia Burkhardt; Phillip Stahl; Maria C Tsourlakis; Melanie Bauer; Pierre Tennstedt; Markus Graefen; Stefan Steurer; Hueseyin Sirma; Guido Sauter; Thorsten Schlomm; Ronald Simon; Sarah Minner
Journal:  Mod Pathol       Date:  2014-04-25       Impact factor: 7.842

4.  Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.

Authors:  Carlos L Morais; Jeong S Han; Jennifer Gordetsky; Michael S Nagar; Ann E Anderson; Stephen Lee; Jessica L Hicks; Ming Zhou; Cristina Magi-Galluzzi; Rajal B Shah; Jonathan I Epstein; Angelo M De Marzo; Tamara L Lotan
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

5.  Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer.

Authors:  Christopher Weier; Michael C Haffner; Timothy Mosbruger; David M Esopi; Jessica Hicks; Qizhi Zheng; Helen Fedor; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Pathol       Date:  2013-06       Impact factor: 7.996

6.  TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.

Authors:  Kyung Park; James T Dalton; Ramesh Narayanan; Christopher E Barbieri; Michael L Hancock; David G Bostwick; Mitchell S Steiner; Mark A Rubin
Journal:  J Clin Oncol       Date:  2013-12-02       Impact factor: 44.544

7.  Tracking the origin of metastatic prostate cancer.

Authors:  Johan Lindberg; Anna Kristiansen; Peter Wiklund; Henrik Grönberg; Lars Egevad
Journal:  Eur Urol       Date:  2014-09-22       Impact factor: 20.096

8.  Tracking the clonal origin of lethal prostate cancer.

Authors:  Michael C Haffner; Timothy Mosbruger; David M Esopi; Helen Fedor; Christopher M Heaphy; David A Walker; Nkosi Adejola; Meltem Gürel; Jessica Hicks; Alan K Meeker; Marc K Halushka; Jonathan W Simons; William B Isaacs; Angelo M De Marzo; William G Nelson; Srinivasan Yegnasubramanian
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

9.  Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion.

Authors:  B Gumuskaya; B Gurel; H Fedor; H-L Tan; C A Weier; J L Hicks; M C Haffner; T L Lotan; A M De Marzo
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-04-02       Impact factor: 5.554

10.  Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.

Authors:  Colin S Cooper; Rosalind Eeles; David C Wedge; Peter Van Loo; Anne Y Warren; Christopher S Foster; Hayley C Whitaker; Ultan McDermott; Daniel S Brewer; David E Neal; Gunes Gundem; Ludmil B Alexandrov; Barbara Kremeyer; Adam Butler; Andrew G Lynch; Niedzica Camacho; Charlie E Massie; Jonathan Kay; Hayley J Luxton; Sandra Edwards; ZSofia Kote-Jarai; Nening Dennis; Sue Merson; Daniel Leongamornlert; Jorge Zamora; Cathy Corbishley; Sarah Thomas; Serena Nik-Zainal; Sarah O'Meara; Lucy Matthews; Jeremy Clark; Rachel Hurst; Richard Mithen; Robert G Bristow; Paul C Boutros; Michael Fraser; Susanna Cooke; Keiran Raine; David Jones; Andrew Menzies; Lucy Stebbings; Jon Hinton; Jon Teague; Stuart McLaren; Laura Mudie; Claire Hardy; Elizabeth Anderson; Olivia Joseph; Victoria Goody; Ben Robinson; Mark Maddison; Stephen Gamble; Christopher Greenman; Dan Berney; Steven Hazell; Naomi Livni; Cyril Fisher; Christopher Ogden; Pardeep Kumar; Alan Thompson; Christopher Woodhouse; David Nicol; Erik Mayer; Tim Dudderidge; Nimish C Shah; Vincent Gnanapragasam; Thierry Voet; Peter Campbell; Andrew Futreal; Douglas Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

View more
  21 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

2.  Mutation Profiling Indicates High Grade Prostatic Intraepithelial Neoplasia as Distant Precursors of Adjacent Invasive Prostatic Adenocarcinoma.

Authors:  Sean J Gerrin; Adam G Sowalsky; Steven P Balk; Huihui Ye
Journal:  Prostate       Date:  2016-06-08       Impact factor: 4.104

3.  Small cell-like glandular proliferation of prostate: a rare lesion not related to small cell prostate cancer.

Authors:  Oleksandr N Kryvenko; Sean R Williamson; Kiril Trpkov; Nilesh S Gupta; Daniel Athanazio; Martin K Selig; Paul Taylor Smith; Cristina Magi-Galluzzi; Merce Jorda
Journal:  Virchows Arch       Date:  2016-10-14       Impact factor: 4.064

4.  Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer.

Authors:  Ganesh S Palapattu; Simpa S Salami; Andi K Cani; Daniel H Hovelson; Lorena Lazo de la Vega; Kelly R Vandenberg; Jarred V Bratley; Chia-Jen Liu; Lakshmi P Kunju; Jeffery S Montgomery; Todd M Morgan; Shyam Natarajan; Jiaoti Huang; Scott A Tomlins; Leonard S Marks
Journal:  Clin Cancer Res       Date:  2016-10-07       Impact factor: 12.531

Review 5.  Histopathology of Prostate Cancer.

Authors:  Peter A Humphrey
Journal:  Cold Spring Harb Perspect Med       Date:  2017-10-03       Impact factor: 6.915

6.  ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.

Authors:  Carlos L Morais; Liana B Guedes; Jessica Hicks; Alexander S Baras; Angelo M De Marzo; Tamara L Lotan
Journal:  Hum Pathol       Date:  2016-05-14       Impact factor: 3.466

7.  Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy.

Authors:  Charlotte F Kweldam; Intan P Kümmerlin; Daan Nieboer; Esther I Verhoef; Ewout W Steyerberg; Theodorus H van der Kwast; Monique J Roobol; Geert J van Leenders
Journal:  Mod Pathol       Date:  2016-03-04       Impact factor: 7.842

Review 8.  Molecular Pathology of High-Grade Prostatic Intraepithelial Neoplasia: Challenges and Opportunities.

Authors:  Levent Trabzonlu; Ibrahim Kulac; Qizhi Zheng; Jessica L Hicks; Michael C Haffner; William G Nelson; Karen S Sfanos; Onur Ertunc; Tamara L Lotan; Christopher M Heaphy; Alan K Meeker; Srinivasan Yegnasubramanian; Angelo M De Marzo
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 9.  Clonal origin and spread of metastatic prostate cancer.

Authors:  Jamie L Van Etten; Scott M Dehm
Journal:  Endocr Relat Cancer       Date:  2016-03-21       Impact factor: 5.678

10.  A basal cell defect promotes budding of prostatic intraepithelial neoplasia.

Authors:  Mengdie Wang; Raymond B Nagle; Beatrice S Knudsen; Gregory C Rogers; Anne E Cress
Journal:  J Cell Sci       Date:  2016-09-08       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.